Fahima Madouri1,2, Noëlline Guillou2, Louis Fauconnier1, Tiffany Marchiol1, Nathalie Rouxel1, Pauline Chenuet2, Aurélie Ledru1, Lionel Apétoh3,4,5, François Ghiringhelli3,4,5, Mathias Chamaillard6, Song Guo Zheng7,8, Fabrice Trovero1, Valérie Quesniaux2, Bernhard Ryffel2, Dieudonnée Togbe1,2
1Artimmune SAS, 45100 Orléans, France
2Laboratory ofExperimental and Molecular Immunology and Neurogenetics (INEM), UMR 7355 CNRS-University of Orleans, F-45071 Orleans-Cedex2, France
3Centre Georges François Leclerc, Dijon, France
4Faculté de Médecine, University of Bourgogne, Dijon, France
5INSERM, U866, Dijon, France
6CIIL – Center for Infection and Immunity of Lille, INSERM U1019, Institut Pasteur, Lille, France
7Clinical Immunology Section, Third Affiliated Hospital at Sun Yat-Sen University, Guangzhou 510630, China
8Division of Rheumatology, Penn State Milton S. Hershey Medical Center, Hershey, PA 17033, USA